A 17-gene genomic prostate score (GPS) as a predictor of biochemical (BCR) and clinical recurrence (CR) in men with surgically treated intermediate- and high-risk prostate cancer (PCa). This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results